The Asset Allocator: Intel’s Cure Precedes Its Illness

07:32 | May 18th, 2021

Intel’s detractors criticize the company for falling behind competitors in data-center sales, for reducing buybacks and for declining profit margins. But it is when a company is down that its stock pr...Show More